Jamieson Wellness (TSE:JWEL) Price Target Cut to C$35.00

Jamieson Wellness (TSE:JWEL) had its price objective dropped by equities researchers at Royal Bank of Canada from C$38.00 to C$35.00 in a note issued to investors on Friday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 31.73% from the company’s current price.

Several other research analysts also recently issued reports on JWEL. Canaccord Genuity Group reduced their price target on shares of Jamieson Wellness from C$42.00 to C$41.25 and set a “buy” rating on the stock in a research report on Tuesday, July 25th. Stifel Nicolaus reduced their price target on shares of Jamieson Wellness from C$50.00 to C$45.00 and set a “buy” rating on the stock in a research report on Thursday, September 21st. TD Securities reduced their price target on shares of Jamieson Wellness from C$50.00 to C$42.00 and set an “action list buy” rating on the stock in a research report on Friday. Finally, CIBC reduced their price target on shares of Jamieson Wellness from C$37.00 to C$32.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 8th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of C$38.66.

Jamieson Wellness Stock Up 13.3 %

JWEL opened at C$26.57 on Friday. The firm’s 50-day simple moving average is C$24.70 and its 200-day simple moving average is C$28.08. The company has a debt-to-equity ratio of 60.56, a quick ratio of 1.08 and a current ratio of 2.56. Jamieson Wellness has a twelve month low of C$22.10 and a twelve month high of C$37.48. The firm has a market cap of C$1.12 billion, a price-to-earnings ratio of 23.94 and a beta of 0.36.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products including vitamins, herbal and mineral nutritional supplements for humans in Canada, the United States of America, and internationally. It operates through Jamieson Brands and Strategic Partners segments.